| 1. |
- Bill-Axelson, Anna, et al.
(författare)
-
Radical prostatectomy versus watchful waiting in localized prostate cancer : the Scandinavian prostate cancer group-4 randomized trial
- 2008
-
Ingår i: Journal of the National Cancer Institute. - : Oxford University Press. - 0027-8874 .- 1460-2105. ; 100:16, s. 1144-1154
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: The benefit of radical prostatectomy in patients with early prostate cancer has been assessed in only one randomized trial. In 2005, we reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up. We now report results after 3 more years of follow-up.METHODS: From October 1, 1989, through February 28, 1999, 695 men with clinically localized prostate cancer were randomly assigned to radical prostatectomy (n = 347) or watchful waiting (n = 348). Follow-up was complete through December 31, 2006, with histopathologic review and blinded evaluation of causes of death. Relative risks (RRs) were estimated using the Cox proportional hazards model. Statistical tests were two-sided.RESULTS: During a median of 10.8 years of follow-up (range = 3 weeks to 17.2 years), 137 men in the surgery group and 156 in the watchful waiting group died (P = .09). For 47 of the 347 men (13.5%) who were randomly assigned to surgery and 68 of the 348 men (19.5%) who were not, death was due to prostate cancer. The difference in cumulative incidence of death due to prostate cancer remained stable after about 10 years of follow-up. At 12 years, 12.5% of the surgery group and 17.9% of the watchful waiting group had died of prostate cancer (difference = 5.4%, 95% confidence interval [CI] = 0.2 to 11.1%), for a relative risk of 0.65 (95% CI = 0.45 to 0.94; P = .03). The difference in cumulative incidence of distant metastases did not increase beyond 10 years of follow-up. At 12 years, 19.3% of men in the surgery group and 26% of men in the watchful waiting group had been diagnosed with distant metastases (difference = 6.7%, 95% CI = 0.2 to 13.2%), for a relative risk of 0.65 (95% CI = 0.47 to 0.88; P = .006). Among men who underwent radical prostatectomy, those with extracapsular tumor growth had 14 times the risk of prostate cancer death as those without it (RR = 14.2, 95% CI = 3.3 to 61.8; P < .001).CONCLUSION: Radical prostatectomy reduces prostate cancer mortality and risk of metastases with little or no further increase in benefit 10 or more years after surgery.
|
|
| 2. |
- Sävenhed, Hans, et al.
(författare)
-
Heja Halland : utvärdering av en trafiksäkerhetskampanj
- 1996
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- I Halland genomfördes under åren 1990-94 en trafiksäkerhetskampanj under namnet Heja Halland. Målsättningen var att under fem år reducera olyckorna med 30 %. Grundidén har varit att utan pekpinnar och förmynderi få alla hallänningar engagerade i trafiksäkerhetsarbetet, genom att visa hänsyn och samspela med andra trafikanter. Kommunikationen med hallänningarna har huvudsakligen förts via gratistidningen Heja Halland och genom ett nära samarbete med lokalradion.VTT fick i december 1993 i uppdrag att dokumentera och utvärdera kampanjen.Utvärderingen redovisas i tre i princip fristående kapitel. I det första redogörs för tre undersökningar av beteendevetenskaplig karaktär. I det andra redovisas en beskrivning av utvecklingen för antalet skadade och dödade, medan det tredje omfattar en analys av utvecklingen baserad på personskadeolyckor. I de båda senare fallen har SCB:s officiella statistik baserad på polisrapporterade olyckor varit källa.Sammanfattningsvis kan man säga att man i Hallands län ej uppnått de mål vad avser reduktion av olyckor som sattes vid kampanjstarten. Däremot har det skett en påtaglig reduktion av döds- och svåra personskadeolyckor. Inga säkra slutsatser kan dock dras om orsakerna till detta. Inte heller hur resultaten kan generaliseras. Detta bland annat på grund av att man startade utifrån ett dåligt läge vad gällde just de allvarligaste olyckorna.
|
|
| 3. |
- Adolfsson, Jan, et al.
(författare)
-
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005
- 2007
-
Ingår i: Scandinavian Journal of Urology and Nephrology. - : Informa UK Limited. - 0036-5599 .- 1651-2065. ; 41:6, s. 456-477
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE: The incidence of prostate cancer is rising rapidly in Sweden and there is a need to better understand the pattern of diagnosis, tumor characteristics and treatment. MATERIAL AND METHODS: Between 1996 and 2005, all new cases of adenocarcinoma of the prostate gland were intended to be registered in the National Prostate Cancer Register (NPCR). This register contains information on diagnosing unit, date of diagnosis, cause of diagnosis, tumor grade, tumor stage according to the TNM classification in force, serum prostate-specific antigen (PSA) levels at diagnosis and primary treatment given within the first 6 months after diagnosis. RESULTS: In total, 72,028 patients were registered, comprising >97% of all pertinent incident cases of prostate cancer in the Swedish Cancer Register (SCR). During the study period there was a considerable decrease in median age at the time of diagnosis, a stage migration towards smaller tumors, a decrease in median serum PSA values at diagnosis, a decrease in the age-standardized incidence rate of men diagnosed with distant metastases or with a PSA level of > 100 ng/ml at diagnosis and an increase in the proportion of tumors with Gleason score <6. Relatively large geographical differences in the median age at diagnosis and the age-standardized incidence of cases with category T1c tumors were observed. Treatment with curative intent increased dramatically and treatment patterns varied according to geographical region. In men with localized tumors and a PSA level of <20 ng/ml at diagnosis, expectant treatment was more commonly used in those aged > or =75 years than in those aged <75 years. Also, the pattern of endocrine treatment varied in different parts of Sweden. CONCLUSIONS: All changes in the register seen over time are consistent with increased diagnostic activity, especially PSA testing, resulting in an increased number of cases with early disease, predominantly tumors in category T1c. The patterns of diagnosis and treatment of prostate cancer vary considerably in different parts of Sweden. The NPCR continues to be an important source for research, epidemiological surveillance of the incidence, diagnosis and treatment of prostate cancer.
|
|
| 4. |
- Ahlén, Ingemar, et al.
(författare)
-
Bats and offshore wind turbines studied in southern Scandinavia
- 2007
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- A pilot study 2002-2003 at turbines on land showed that certain locations in the landscape could explain some of the casualty risks and the main reasons for collisions were found. During the 2005 introductory studies and in the project 2006 on bats in offshore areas in Kalmarsund we could confirm earlier known flyways from coastal points and found an extensive activity of passing migrants but also of resident species coming from various directions to areas with an abundance of insects. Observations were made at Utgrunden and Yttre Stengrund in Kalmarsund in the Baltic Sea and in Öresund between Sweden and Denmark. The observers onboard the boats and at the coastal points where bats take off used ultrasound detectors, strong portable spotlights and at special times also thermal camera. Boxes for automatic recording of bats were used on land, were placed on the turbines, and on the boat's cap. These methods resulted in a total of 12 354 observations of bats, 3 830 over the sea and 8 524 on land. Bats fly over the sea in winds up to about 10 m/s, a major part of the activity took place at wind speeds less than 5 m/s. Bats of 10 species were observed on the open sea and all of them were foraging at suitable weather conditions, which means calm weather or light breeze. The bats did not avoid the turbines. On the contrary they stayed for shorter or longer periods hunting close to the windmills because of the accumulation of flying insects. Hunting close to the blades was observed, why the risk of colliding might be comparable to land-based turbines. Bats also used wind turbines for resting. Insects were collected at places and times when bats were observed feeding. Chironomids were dominating, but we also found many other flying species of other insect groups. Insects, but probably also crustaceans, were caught by bats in the water surface. Some terrestrial species occurred among the insects and spiders that were drifting in the air. At times we suppose that their origin was in the Baltic Republics or Russia. It was earlier completely unknown that many bat species, migratory and non-migratory, regularly use this food resource on the open sea far from the coasts in the late summer and early autumn. With radar on Utgrunden's lighthouse data on movements of the largest bat species, mainly Nyctalus noctula, could be studied. This gave data on flyways, directions, movement patterns when foraging, especially near the turbines. With the radar it was possible to measure altitude and the results showed that almost all activity took place below 40 m above sea level, while only a few cases of higher flight was recorded. Observations from boat showed that altitude was very variable according to the available insects. Bats were seen hunting from the water surface up to the upper part of the windmills. Need of further research and developing methods is discussed in the report. An updated risk assessment is presented. A standpoint today is that areas with concentrated flyways and foraging habitats with an abundance of flying insects must be very carefully examined if new windmills are planned. The collision risk at offshore wind power parks is impossible to study as long as there are no such parks. Investigations on bats needed for environmental impact assessments are suggested. To minimize the casualty risks at existing turbines further research is needed. Some measures to take have been discussed. In certain cases it is probably most effective to move a turbine a relative short distance because of the sometimes short edges of the flyways and also the insect rich habitats. Another method is to stop the turbine during periods of high risk. Because the accumulation of insects is the reason for bats hunting close to the blades methods to reduce the amount of flying insects at the turbines would be of interest. Methods to keep the bats away from the turbines do not exist and some such ideas might also have negative effects on other animals and also on humans.
|
|
| 5. |
- Ahlén, Ingemar, et al.
(författare)
-
Fladdermöss och havsbaserade vindkraftverk studerade i södra Skandinavien
- 2007
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- En pilotundersökning 2002-2003 vid vindkraftverk på land i Sydsverige visade på lägen i landskapet där riskerna för kollisioner var förhöjda samt de viktigaste orsakerna till olyckorna. Under 2005 års förstudie och i projektet 2006 vid havsbaserade vindkraftverk kunde vi bekräfta tidigare utpekade utsträck över havet av fladdermöss i Kalmarsund och fann en omfattande aktivitet av passerande migranter men även av stationära arter som från olika håll flög ut till områden med mycket insekter. Observationer gjordes framför allt vid Utgrunden och Yttre Stengrund i Kalmarsund och i Öresund. Observatörerna på båtarna och på utsträcksplatser på land använde ultraljudsdetektorer, starka strålkastare och vid vissa tillfällen värmekamera. Automatiskt registrerande boxar användes på land, hängdes på vindkraftverken och placerades på båtens kapp. Metoderna resulterade i totalt 12 354 observationer av fladdermöss, varav 3 830 över havet och 8 524 på land. Fladdermöss flög över havet i vindstyrkor upp till ca 10 m/s, men en stor del av aktiviteten skedde vid vindstyrkor mindre än 5 m/s. Fladdermöss av 10 arter observerades ute till havs och alla sågs söka föda vid tjänlig väderlek, d.v.s. främst vid svaga vindar och blankvatten. Fladdermössen undvek inte vindkraftverken. Tvärtom stannade de ofta till för insektsjakt nära verken på grund den ansamling av insekter som förekom där. Jakt helt intill rotorbladen observerades, vilket innebär att kollisionsrisken kan vara jämförbar med landbaserade verk. Fladdermöss kan bevisligen också använda vindkraftverk som viloplats, vilket har skett i det mest insektsrika området vi undersökte.Insamling av insekter gjordes på de platser och vid de tillfällen då fladdermöss sågs jaga. Fjädermyggor dominerade, men många andra flygande arter av andra insektsgrupper var också företrädda. Insekter, och troligen även några kräftdjur, togs också i havsytan. Några arter av landlevande arter förekom bland de mängder av insekter och spindlar som drev omkring i luftmassorna. Vid vissa tillfällen antar vi att de har kommit från Balticum eller Ryssland. Det har inte tidigare varit känt att många fladdermusarter, stationära och migrerande, regelbundet utnyttjar denna födoresurs långt ute i havet under eftersommaren och tidiga hösten.Med radarn på Utgrundens fyr kunde data om de största arterna, troligen mest stor fladdermus, insamlas. Det gällde flygvägar, riktningar, rörelsemönster vid födosök, speciellt i närheten av vindkraftverken. Med radarn kunde fastställas att nästan all aktivitet skedde under 40 m höjd, endast enstaka fladdermöss flög högre vid sträckflykt. Direktobservationerna från båt visade att fladdermössen varierade höjd efter tillgången på insekter. Sålunda förekom flyghöjder från havsytan upp till verkens övre delar.Behov av fortsatt forskning och utvecklingsarbete diskuteras i rapporten. Vidare görs en uppdaterad riskbedömning. Ståndpunkten är nu att områden med koncentrerade flygvägar och insektsrika födosöksområden är de som måste granskas extra noga inför lokalisering av nya vindkraftverk. Risken för kollisioner vid ren passage genom stora vindkraftsparker kan inte bedömas, eftersom det ännu inte hunnit uppföras några parker. Förslag ges om vilka undersökningar som bör föregå lokaliseringsbesluten. Några krav på vad kontrollprogram vid utbyggnad bör innefatta diskuteras också. För att minska riskerna vid befintliga vindkraftverk krävs fortsatt forskning och metodutveckling. Några åtgärder som diskuterats hittills redovisas i rapporten. I svåra fall är sannolikt den effektivaste åtgärden att flytta vindkraftverket. Det kan troligen räcka med relativt korta avstånd på grund av att flygvägarna kan ha skarpa gränser och att de insektsrika födosöksbiotoperna också kan vara ganska väl avgränsade. En annan åtgärd kan vara att låta vindkraftverket stå stilla vid de tider då risken för kollisioner är stor. Eftersom ansamling av insekter kring vindkraftverken kan vara en viktig orsak till jakt nära rotorbladen kan man också tänka sig åtgärder för att minska mängden flygande insekter runt verken. Fungerande metoder som kan få fladdermöss att väja för vindkraftverk finns inte och idéer som förekommit kan ha negativa effekter i form av störningar eller skador på andra djurarter och för människor.
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
- Bargholtz, Chr., et al.
(författare)
-
Measurement of the eta -> pi(+)pi(-)e(+)e(-) decay branching ratio
- 2007
-
Ingår i: Physics Letters B. - : Elsevier BV. - 0370-2693 .- 1873-2445. ; 644:5-6, s. 299-303
-
Tidskriftsartikel (refereegranskat)abstract
- The reaction pd -> He-3 eta at threshold was used to provide a clean source of eta mesons for decay studies with the WASA detector at CELSIUS. The branching ratio of the decay eta -> pi(+)pi(-)e(+)e(-) is measured to be (4.3 +/- 1.3 +/- 0.4) x 10(-4).
|
|
| 10. |
- Bargholtz, Chr., et al.
(författare)
-
The WASA detector facility at CELSIUS
- 2008
-
Ingår i: Nuclear Instruments and Methods in Physics Research Section A. - : Elsevier BV. - 0168-9002 .- 1872-9576. ; 594:3, s. 339-350
-
Tidskriftsartikel (refereegranskat)abstract
- The WASA 4 pi multidetector system, aimed at investigating light meson production in light ion collisions and eta meson rare decays at the CELSIUS storage ring in Uppsala is presented. A unique feature of the system is the use of hydrogen pellets as internal targets for the first time. A detailed description of the design, together with the anticipated and achieved performance parameters are given. (C) 2008 Elsevier B.V. All rights reserved.
|
|
| 11. |
- Bashkanov, M., et al.
(författare)
-
Double-Pionic Fusion of Nuclear Systems and the "ABC" Effect : Approaching a Puzzle by Exclusive and Kinematically Complete Measurements
- 2009
-
Ingår i: Physical Review Letters. - 0031-9007 .- 1079-7114. ; 102:5, s. 052301-
-
Tidskriftsartikel (refereegranskat)abstract
- The ABC effect-a puzzling low-mass enhancement in the pi pi invariant mass spectrum, first observed by Abashian, Booth, and Crowe-is well known from inclusive measurements of two-pion production in nuclear fusion reactions. Here we report on the first exclusive and kinematically complete measurements of the most basic double-pionic fusion reaction pn -> d pi(0)pi(0) at beam energies of 1.03 and 1.35 GeV. The measurements, which have been carried out at CELSIUS-WASA, reveal the ABC effect to be a (pi pi)(I=L=0) channel phenomenon associated with both a resonancelike energy dependence in the integral cross section and the formation of a Delta Delta system in the intermediate state. A corresponding simple s-channel resonance ansatz provides a surprisingly good description of the data.
|
|
| 12. |
- Bashkanov, M., et al.
(författare)
-
Measurement of the slope parameter for the η → 3π0 decay in the pp → ppη reaction
- 2007
-
Ingår i: Physical Review C. Nuclear Physics. - 0556-2813 .- 1089-490X. ; 76:4, s. 048201-
-
Tidskriftsartikel (refereegranskat)abstract
- The CELSIUS-WASA setup is used to measure the 3π0 decay of η mesons produced in pp interactions with beam kinetic energies of 1.36 and 1.45 GeV. The efficiency-corrected Dalitz plot and density distributions for this decay are shown, together with a fit of the quadratic slope parameter α yielding α = −0.026 ± 0.010(stat) ± 0.010(syst). This value is compared to recent experimental results and theoretical predictions.
|
|
| 13. |
- Becker, Charlotte, et al.
(författare)
-
Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater
- 2000
-
Ingår i: Urology. - 1527-9995. ; 55:5, s. 694-699
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVES: To investigate the clinical value of human glandular kallikrein 2 (hK2) compared with free (f) and total (t) prostate-specific antigen (PSA) in the early detection of prostate cancer (PCa). METHODS: In PCa screening conducted in 1995 to 1996 in Goteborg, Sweden, 5853 of 9811 randomly selected men (aged 50 to 66 years; median 61) accepted PSA testing; those with tPSA levels of 3. 0 ng/mL or greater were offered digital rectal examination, transrectal ultrasound, and sextant biopsies. Serum from 604 of 611 biopsied men (18% with positive digital rectal examinations, tPSA range 3.0 to 220 ng/mL, 144 men with PCa) was analyzed for hK2 (research assay) and tPSA and fPSA (Prostatus). Sera were stored at -20 degrees C for a maximum of 2 weeks for tPSA and fPSA and 3 years for hK2. RESULTS: hK2 levels and hK2 x tPSA/fPSA values were significantly elevated in men with PCa. Receiver operating characteristic data revealed that the area under the curve for hK2 x tPSA/fPSA was significantly greater than that for tPSA and greater, but not significantly greater, than that for percent fPSA. Also, the cancer-detecting sensitivity was significantly improved (P <0.05) using hK2 x tPSA/fPSA compared with tPSA and percent fPSA at specificity levels of 75% to 90%. At 75% specificity, a sensitivity of 74% was obtained compared with 64% or 54% using percent fPSA or tPSA; at 90% specificity, the corresponding sensitivity level was 55%, 41%, and 36%, respectively. CONCLUSIONS: Discrimination of men with and without PCa in a randomly selected population was improved by measuring hK2 in addition to tPSA and fPSA.
|
|
| 14. |
- Becker, Charlotte, et al.
(författare)
-
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum
- 2000
-
Ingår i: Journal of Urology. - 1527-3792. ; 163:1, s. 311-316
-
Tidskriftsartikel (refereegranskat)abstract
- PURPOSE: To investigate the clinical value of measuring human glandular kallikrein 2 (hK2) compared with free and total prostate specific antigen (PSA-F and PSA-T) in serum from patients with prostate disease. MATERIALS AND METHODS: Serum from healthy controls, from men with benign prostate hyperplasia (BPH), clinically localized prostate cancer (PCa), and advanced PCa were analyzed for hK2 (using an in-house-research assay with detection limit of 0.05 ng./mL and <0.1% cross-reaction with PSA) and for PSA-F and PSA-T (using the Dual Prostatus assay from EG&G Wallac). RESULTS: HK2 concentrations were <0.05 ng./mL in 50/50 healthy volunteers but significantly higher (p <0.0001) and > or =0.05 ng./mL in 28/54 (52%) patients with BPH. In comparison to these men, the hK2 levels were significantly higher (p <0.0001, median 0.085 ng./mL) and > or =0.05 ng./mL in 100/136 (74%) men with clinically localized PCa. Compared with localized PCa, the hK2 levels were significantly higher (p <0.0001, median 0.57 ng./mL) and > or =0.05 ng./mL in 55/57 (96%) patients with advanced PCa. The median hK2 levels ranged from 1.3 to 1.6% of those of PSA-T in all three patient groups, whereas percent hK2/PSA-F and hK2 x PSA-T/PSA-F levels were significantly higher in cancer patients compared with those with BPH. In the discrimination of clinically localized PCa from BPH, hK2 x PSA-T/PSA-F gave the largest area under the receiver operating curve (AUC = 0.81) and significantly (p = 0.025) larger AUC than PSA-T alone (0.70). Further, at 95% sensitivity there was significant gain in specificity, and at specificity levels of 90 to 95% there was significant gain in sensitivity using the measurements of PSA-T+PSA-F+hK2 compared with analysis of PSA-T and/or percent free PSA. CONCLUSIONS: Discrimination of patients with benign prostate disease from those with prostate cancer was significantly enhanced using measurements of hK2 in addition to those of PSA-T and PSA-F. Percent hK2/PSA-F was higher in PCa than in BPH, a phenomena not yet understood.
|
|
| 15. |
- Becker, Charlotte, et al.
(författare)
-
Sensitive and specific immunodetection of human glandular kallikrein 2 in serum
- 2000
-
Ingår i: Clinical Chemistry. - 0009-9147. ; 46:2, s. 198-206
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Human glandular kallikrein 2 (hK2) is expressed in the prostate and is present in serum from men with prostate cancer. Specific detection in serum is difficult mainly because of low concentrations and immunological cross-reactivity with prostate-specific antigen (PSA). Our objectives were to design an assay with improved analytical detection and functional sensitivity and nonsignificant cross-reactivity with PSA, and to characterize different immunoreactive forms of hK2. METHODS: In the assay, critical PSA epitopes were blocked with four monoclonal antibodies (MAbs) specific for PSA. Subsequently, hK2 was captured using a MAb against hK2 (5% cross-reactivity with PSA), and after washing, hK2 was detected by a europium-labeled MAb with identical affinity for hK2 and PSA. RESULTS: The analytical detection limit was <10 ng/L, and functional sensitivity was 30 ng/L. Cross-reaction with PSA was <0.01%. Between-assay imprecision was 3.1% for 1600 ng/L hK2 and 4. 8% for 160 ng/L hK2; corresponding values for within-assay precision were 1.9% and 4.5%, respectively. Complexes of hK2-alpha(1)-antichymotrypsin (ACT) were detected in vitro with -6% bias compared with the free form of hK2. Gel filtration of patient samples showed that hK2 correlated in size mainly with free hK2; only 4-19% corresponded to hK2 possibly complexed with ACT or protein C inhibitor. CONCLUSIONS: Our assay had extremely low cross-reactivity with PSA, provided a very low detection limit, and allowed close to equimolar detection of the free and complexed forms of hK2. Moreover, we found that free hK2 is the predominant immunoreactive form of hK2 in serum.
|
|
| 16. |
- Becker, Charlotte, et al.
(författare)
-
Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
- 2003
-
Ingår i: Journal of Urology. - : Ovid Technologies (Wolters Kluwer Health). - 1527-3792 .- 0022-5347. ; 170:4 Pt 1, s. 1169-1174
-
Tidskriftsartikel (refereegranskat)abstract
- Purpose: We investigated the value of serum measurements for glandular kallikrein 2 (hK2), and free (f) and total (t) prostate specific antigen (PSA) in a second round of biannual screening for prostate cancer. Materials and Methods: In 1995 to 1996, 5,853 of 9,811 randomly selected men in Goteborg, Sweden 50 to 66 years old had PSA measurements. Of 660 men 611 with tPSA 3 ng/ml or greater underwent biopsy and 145 had cancer. All were re-invited 2 years later for PSA testing, and 506 of 596 men with tPSA 3 ng/ml or greater underwent biopsy and 113 cancers were detected. We analyzed hK2, tPSA and fPSA in 423 of 453 (93%) men who underwent biopsy in 1997 to 1998 who were also screened in 1995 to 1996. Results: The 99 of 423 (23%) men who underwent biopsy diagnosed with prostate cancer in 1997 to 1998 had significantly different tPSA, percent fPSA and hK2 x tPSA/fPSA compared to the men with negative biopsies from 2 years earlier. The largest area under curve was obtained for hK2 x tPSA/fPSA in serum from 1995 to 1996 and from 1997 to 1998, but the difference was not significant compared to tPSA and percent fPSA. In serum from 1997 to 1998 measurements of hK2 x tPSA/fPSA gave significantly higher specificity than tPSA at 85% sensitivity, and significantly higher specificity than tPSA and percent fPSA at 70% to 75% sensitivity. In addition, levels of hK2 and hK2 x tPSA/fPSA manifested a significantly greater 2-year increase in men with cancer compared to those with benign biopsies. Conclusions: In men with tPSA levels 3.0 ng/ml or greater who were not diagnosed with cancer during a first round of screening, hK2 measurements enhanced specificity compared to tPSA testing at moderately high sensitivity, and manifested a greater 2-year increase in men with cancer.
|
|
| 17. |
- Bergström, Ulrica, 1970-
(författare)
-
Fragility fractures in fragile people : epidemiology of the age quake
- 2009
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- Osteoporosis-related fracture is already today a major public health problem and the number of hip fractures is expected to double to 2030. Sweden has one of the highest hip fracture incidences worldwide. This may be explained by several factors: e.g. age, genetic, climatologic, geographic and a relative vitamin D deficiency, secondary to the limited sunlight exposure especially during winter months. Intrinsic and extrinsic factors contribute to a fracture, although a prior low energy fracture is one of the strongest predictors for a subsequent one and this should be a target for secondary fracture prevention in an orthopaedic setting. Since 1993 all injured patients admitted to the emergency floor and all in-hospital fractures at Umeå University Hospital, Sweden, were registered according to the Injury Data Base, former EHLASS. There were 31,173 fracture events (one or more fractures at the same time), of which 13,931 were in patients’ ≥ 50 years old. The fracture database was co analyzed with the Northern Sweden Health and Disease Study cohort in a nested case-control study for investigations of associations between osteoporotic fracture and serum markers, lifestyle data, nutrition etc. We found that there were differences in fracture pattern depending on age and sex. Both injury mechanism and fracture site were strongly dependent of age. The most severe fragility fracture, hip fracture, had a decreasing incidence. However, the incidence curve was right-shifting leading to an increase, both in numbers and in incidence of hip fractures among the oldest female. To identify people at high risk for fractures, re-fracture patients are useful. No less than 21% of the fracture patients had suffered more than one fracture event, accounting for 38% of all fracture events. The total risk ratio for a subsequent fracture was 2.2 (2.1-2.3 95% CI). In males the highest risk for re fracture was in the age cohort 70-79 years (RR 2.7, 2.3-3.2 95% CI), in females > 90 years (RR 3.9, 3.2-4.8 95% CI). Another possible risk factor in this subarctic population is the lack of sunlight, leading to a vitamin D deficit. The overall adjusted risk of sustaining a hip fracture in this population was 2.7 (95%CI:1.3-5.4) in subjects with a serum 25 hydroxyvitamin D below 50 nmol/l. The association was, however, different according to age at baseline. Thus in subjects aged 60 years and above at baseline, the adjusted odds ratio of sustaining a hip fracture was 6.2 (1.2-32.5 95%CI) for the group of individuals with a serum 25OHD below 50 nmol/l, whereas no significant association was found in the youngest age group. In the next 30 years the ongoing demographic changes will accelerate. The World War II baby boomers will cause an age quake. We can already see signs heralding a new fracture pattern: an increasing cohort of mobile but fragile elderly, with considerable co-morbidity is now at risk for fragility fractures. In fracture patients, clinical information is sufficient to pinpoint patients with a high risk for re-fractures. It is therefore clinically important to use the information provided by the fracture event. We suggest that trauma units and primary care units should screen for risk factors and inform patients about the treatment options, and to organize fracture liaison services. This seems to be especially cost-efficient for our oldest and frailest patients. Secondary prophylaxis and follow-up treatment after cardiovascular disorders are now a matter of course worldwide, but the screening for risk factors, in order to prevent a second fracture, is often neglected. This is one of the most important issues of fracture care in the future in order to improve general health.
|
|
| 18. |
- Bergström, Ulrica, 1970-, et al.
(författare)
-
The hip fracture incidence curve is shifting to the right : a forecast of the age-quake
- 2009
-
Ingår i: Acta Orthopaedica. - : Medical Journals Sweden AB. - 1745-3674 .- 1745-3682. ; 80:5, s. 520-524
-
Tidskriftsartikel (refereegranskat)abstract
- Background The number of hip fractures has doubled in the last 30–40 years in many countries. Age-adjusted incidence has been reported to be decreasing in Europe and North America, but is there a decreasing trend in all age groups? Patients and methods This population-based study included all hip-fracture patients over 50 years of age (a total of 2,919 individuals, 31% of whom were men) admitted to Umeå University Hospital, Sweden, from 1993 through 2005. Results The incidence of hip fracture declined between the periods 1993–1996 and 2001–2005: from 706 to 625 hip fractures per 105 women and from 390 to 317 hip fractures per 105 men. However, there was a 114% increase in the number of fractures in women aged 90 or older (12 and 25 hip fractures/year, respectively, in the two time periods). For the period 2001–05, women ≥ 90 years of age accounted for almost the same numbers of hip fractures as women aged 75–79 (27 fractures/year). The rate increased during this period, from 2,700 per 105 women to 3,900 per 105 women > 90 years. In men there were declining trends for both relative and absolute numbers. Interpretation Although age-adjusted incidence declined in the population > 50 years of age, absolute fracture rate and incidence increased in the very old. Women over 90 now have the same absolute number of hip fractures every year as women aged 75–79 years. There was a right-shift in hip fracture distribution towards the oldest old, probably due to an increased number of octo/nonagenarians, a new population of particularly frail old people that hardly existed earlier. Better health among septuagenarians may also have delayed the age at which fractures occurred. This changing pattern will strain orthopedic and geriatric resources even more.
|
|
| 19. |
- Berlowski, M., et al.
(författare)
-
Measurement of eta meson decays into lepton-antilepton pairs
- 2008
-
Ingår i: Physical Review D. Particles and fields. - : American Physical Society. - 0556-2821 .- 1089-4918. ; 77:3, s. 032004-
-
Tidskriftsartikel (refereegranskat)abstract
- A search for rare lepton decays of the eta meson was performed using the WASA detector at CELSIUS. Two candidates for double Dalitz decay eta -> e(+)e(-)e(+)e(-) events are reported with a background of 1.3 +/- 0.2 events. This allows to set an upper limit to the branching ratio of 9.7x10(-5) (90% CL). The branching ratio for the decay eta -> e(+)e(-)gamma is determined to (7.8 +/- 0.5(stat)+/- 0.8(syst))x10(-3) in agreement with world average value. An upper limit (90% CL) for the branching ratio for the eta -> e(+)e(-) decay is 2.7x10(-5) and a limit for the sum of the eta ->mu(+)mu(-)mu(+)mu(-) and eta ->pi(+)pi(-)mu(+)mu(-) decays is 3.6x10(-4).
|
|
| 20. |
- Bjartell, Anders, et al.
(författare)
-
Time-resolved fluorescence in immunocytochemical detection of prostate-specific antigen in prostatic tissue sections
- 1999
-
Ingår i: Histochemical Journal. - 0018-2214. ; 31:1, s. 45-52
-
Tidskriftsartikel (refereegranskat)abstract
- Chelates with fluorescent lanthanides such as europium and terbium are widely used in immunofluorometric assays, e.g. for the measurement of different molecular forms of prostate-specific antigen (PSA) in serum for detection and monitoring of prostate cancer. These chelates have also been introduced as non-radioactive labels in immunocytochemistry and in situ hybridization. In the present study, sections of non-malignant prostate were investigated using monoclonal IgGs against PSA. Detection of specific immunostaining employing time-resolved fluorescence with europium-labeled streptavidin was compared with conventional detection by streptavidin conjugated to horse-radish peroxidase. The high PSA concentration in the tissue produced high intensity, specific time-resolved fluorescence signals in the epithelial cells of the prostate gland without disturbance from non-specific tissue autofluorescence. This allowed short exposure times to be used which resulted in insignificant photobleaching. Two of the three europium-chelates evaluated yielded high signal intensities. Counterstaining was found to be optimal with Gill No. 1-Haematoxylin solution and Merckoglas(TM) was the best mounting medium for the europium chelates tested. In conclusion, time-resolved fluorescence imaging is an attractive alternative to conventional detection of streptavidin conjugated to horse-radish peroxidase, as it provides linear, high intensity, specific signals subsequent to the decay of non-specific tissue autofluorescence.
|
|
| 21. |
- Björk, Thomas, et al.
(författare)
-
Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer
- 1996
-
Ingår i: Urology. - 1527-9995. ; 48:6, s. 882-888
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVES: To compare different forms and ratios of serum prostate-specific antigen (PSA) to determine which form or ratio provides optimal diagnostic specificity and sensitivity in distinguishing between benign prostatic hyperplasia (BPH) and clinically localized prostate cancer. METHODS: Serum samples were obtained from 47 patients with BPH and 39 with clinically localized prostate cancer. Patients with BPH underwent either transurethral resection of the prostate or transurethral microwave thermotherapy. Patients with prostate cancer, all of whom had no metastases on radionucleotide bone scans and no pelvic lymph node involvement, underwent either radical external beam radiation therapy or radical retropubic prostatectomy. All patients had pretreatment serum PSA levels between 1 and 20 ng/mL. The different forms of serum PSA (free PSA [PSA-F], PSA complexed to alpha 1-antichymotrypsin [PSA-ACT], and total PSA [PSA-T]) were measured using different monoclonal antibodies against PSA and ACT and immunofluorometric assay techniques. Furthermore, three ratios (PSA-F/PSA-T, PSA-ACT/PSA-T, and PSA-F/PSA-ACT) were calculated. RESULTS: By receiver operating characteristic curve analysis, the performance of the different forms and ratios were compared. The PSA-F/PSA-T ratio had the greatest area under the curve (AUC, 0.776), significantly larger than that for PSA-T (0.612; P = 0.024). For PSA-ACT/PSA-T, the AUC was 0.695 (P = 0.283 versus PSA-T) and 0.773 for PSA-F/PSA-ACT (P = 0.051 versus PSA-T). At a cutoff level < 0.17, PSA-F/PSA-T had a sensitivity of 79%, a specificity of 66%, and a positive predictive value of 66% compared with 74%, 38%, and 50%, respectively, for PSA-T at a cutoff level > 4.0 ng/mL. CONCLUSIONS: The PSA-F/PSA-T ratio gives the best diagnostic performance compared with that for other forms and ratios of PSA and will reduce the number of prostatic biopsies in patients with BPH.
|
|
| 22. |
- Björk, Thomas, et al.
(författare)
-
Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum
- 1998
-
Ingår i: Urology. - 1527-9995. ; 51:1, s. 57-62
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVES: To study the rates of elimination of total prostate-specific antigen (PSA-T), free PSA (PSA-F), and PSA complexed to alpha 1-antichymotrypsin (PSA-ACT) from blood after radical retropubic prostatectomy (RRP). METHODS: We obtained venous blood from 10 patients with prostate cancer who were undergoing RRP. We analyzed PSA-F and PSA-ACT and equimolar detection of both of these forms together (PSA-T) by using immunofluorometric assays. An attempt was made to fit the serum concentrations of PSA-F, PSA-ACT, and PSA-T for each patient to exponential curves by applying one- and two-compartment models for pharmacokinetic analysis. RESULTS: Manipulation of the prostate during RRP resulted in a 3- to 28-fold increase in PSA-F concentrations in serum. Removal of the prostate resulted in a rapid, biexponential elimination of PSA-F from serum, corresponding to a mean initial (alpha) half-life of 0.81 hours and a mean terminal (beta) half-life of 13.9 hours. Serum PSA-ACT concentrations decreased by 20% to 40% immediately after removal of the gland; the elimination after surgery was slow and nonexponential, corresponding to a mean rate of 0.8 ng/mL/day. The elimination of PSA-T reflects a combination of the elimination patterns for PSA-F and PSA-ACT. CONCLUSIONS: The main proportion of PSA-F is rapidly eliminated from serum, possibly by glomerular filtration. PSA-F released during surgery did not form complexes with ACT, as suggested by the lack of PSA-ACT elevation in serum. The size (approximately 90 kDa) and the extensive in vitro stability of the PSA-ACT complex prevents renal clearance. The nonexponential elimination of the PSA-ACT complex is evidence of a capacity-limited process (e.g., metabolic transformation).
|
|
| 23. |
|
|
| 24. |
|
|
| 25. |
|
|
| 26. |
- Draptchinskaia, Natalia, et al.
(författare)
-
The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia
- 1999
-
Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 21:2, s. 169-75
-
Tidskriftsartikel (refereegranskat)abstract
- Diamond-Blackfan anaemia (DBA) is a constitutional erythroblastopenia characterized by absent or decreased erythroid precursors. The disease, previously mapped to human chromosome 19q13, is frequently associated with a variety of malformations. To identify the gene involved in DBA, we cloned the chromosome 19q13 breakpoint in a patient with a reciprocal X;19 chromosome translocation. The breakpoint occurred in the gene encoding ribosomal protein S19. Furthermore, we identified mutations in RPS19 in 10 of 40 unrelated DBA patients, including nonsense, frameshift, splice site and missense mutations, as well as two intragenic deletions. These mutations are associated with clinical features that suggest a function for RPS19 in erythropoiesis and embryogenesis.
|
|
| 27. |
- Dubaric, Ervin, et al.
(författare)
-
Monte Carlo simulations of the imaging properties of scintillator coated X-ray pixel detectors
- 2000
-
Ingår i: IEEE Nuclear Science Symposium and Medical Imaging Conference. - : IEEE conference proceedings. - 0780365038 ; , s. 6/282-6/285
-
Konferensbidrag (refereegranskat)abstract
- The imaging properties of X-ray pixel detectors depend on the quantum efficiency for X-rays, the generated signal for each X-ray photon and the distribution of the generated signal between different pixels. In a scintillator coated device the signal is generated both by X-ray photons captured in the scintillator and by X-ray photons captured directly in the semiconductor. Hence, the signal-to-noise ratio (SNR) in the image is then a function of the number of photons captured in each of these processes, and the yield of each process, in terms of electron-hole pairs (EHPs) produced in the semiconductor. The full process from the absorption of the X-ray photon to the final signal read out from the detector has been simulated with a combination of the Monte Carlo program MCNP and the commercial carrier transport simulation tool MEDICI. An in house program calculating the light transport between the scintillator and the semiconductor serves as a link
|
|
| 28. |
- Eerola, Riitta, et al.
(författare)
-
Immunoreactivity of recombinant human glandular kallikrein using monoclonal antibodies raised against prostate-specific antigen
- 1997
-
Ingår i: Prostate. - 0270-4137. ; 31:2, s. 84-90
-
Tidskriftsartikel (refereegranskat)abstract
- The gene encoding human glandular kallikrein (KLK2) was expressed in Escherichia coli, and the corresponding protein (hK2) was produced by fermentation. The hK2 was characterized by Western blotting and epitope map using monoclonal antibodies (MAbs) specific for another protease, prostate- specific antigen (PSA) with high structural identity (80%). MAbs that recognized three different epitopes were bound to hK2, representing 7 out of 23 MAbs tested. One epitope was localized to the sequence region around amino acid position 78, which is believed to be glycosylated in hK2. The affinities of MAbs recognizing hK2 were similar to those for PSA, suggesting that common epitopes seem to contain very conserved structures. The results may help in designing specific diagnostic assays for the assessment of prostate cancer.
|
|
| 29. |
- Eldh, Sigrid, et al.
(författare)
-
Framework for Comparing Efficiency, Effectiveness and Applicability of Software Testing Techniques
- 2006
-
Ingår i: Proceedings - Testing: Academic and Industrial Conference - Practice and Research Techniques, TAIC PART 2006. ; , s. 159-170
-
Konferensbidrag (refereegranskat)abstract
- Software testing is expensive for the industry, and always constrained by time and effort. Although there is a multitude of test techniques, there are currently no scientifically based guidelines for the selection of appropriate techniques of different domains and contexts. For large complex systems, some techniques are more efficient in finding failures than others and some are easier to apply than others are. From an industrial perspective, it is important to find the most effective and efficient test design technique that is possible to automate and apply. In this paper, we propose an experimental framework for comparison of test techniques with respect to efficiency, effectiveness and applicability. We also plan to evaluate ease of automation, which has not been addressed by previous studies. We highlight some of the problems of evaluating or comparingtest techniques in an objective manner. We describe our planned process for this multi-phase experimental study. This includes presentation of some of the important measurements to be collected with the dual goals of analyzing the properties of the test technique, as well as validating our experimental framework.
|
|
| 30. |
|
|
| 31. |
|
|
| 32. |
- Fiedler, Markus, et al.
(författare)
-
QoE-based Cross-Layer Design of Mobile Video Systems : Challenges and Concepts
- 2009
-
Konferensbidrag (refereegranskat)abstract
- This conceptual paper focuses on revealing challenges and offering concepts associated with the incorporation of the Quality of Experience (QoE) paradigm into the design of mobile video systems. The corresponding design framework combines application, middleware and networking layer in a unique cross-layer approach, in which all layers shall jointly analyse the quality of the video and its delivery in face of volatile conditions. Particular ingredients of the framework are efficient video processing, advanced realtime scheduling, and reduced-reference metrics on application and network layer.
|
|
| 33. |
- Fändriks, Lars, 1956, et al.
(författare)
-
Can famotidine and omeprazole be combined on a once-daily basis?
- 2007
-
Ingår i: Scandinavian journal of gastroenterology. - : Informa UK Limited. - 0036-5521 .- 1502-7708. ; 42:6, s. 689-94
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE: Prompt and long-standing acid control following once-daily administration of antisecretory drugs is desirable. The objective of this study was to determine whether co-administration of a well-characterized H2-receptor antagonist, famotidine, can be combined with the proton-pump inhibitor omeprazole. MATERIAL AND METHODS: Intragastric 24-h pH-metry was performed in healthy, Helicobacter pylori-negative volunteers on day 1 and after 8 days of daily administration of 20 mg omeprazole, 10 mg famotidine, or a combination of these in a three-way crossover design. RESULTS: A combination of famotidine and omeprazole raised the gastric pH level to >4 in less than 1 h. The percentage of daytime with pH > 4 on day 1 was significantly higher with the combination of omeprazole and famotidine (median: 37%) than that with omeprazole alone (22%; p < 0.05). On day 8, daytime intragastric pH > 4 following treatment with omeprazole (median: 55%) or a combination of omeprazole and famotidine (61%) was superior (p < 0.05) to that with famotidine (21%). On day 1 treatment with both famotidine and the combination (famotidine and omeprazole) showed a significantly shorter time to reach a pH of 4 (medians: 93 and 63 min, respectively) compared with treatment with omeprazole alone (173 min; p < 0.05). CONCLUSIONS: Compared with treatment with omeprazole alone, on day 1 famotidine and omeprazole in combination improved the duration of and time to reach intragastric pH > 4. With regard to duration with pH > 4, the combination therapy was superior to famotidine alone on day 8. The rapid acid control with an H2-receptor antagonist may be combined with the long-lasting antisecretory effect of a proton-pump inhibitor.
|
|
| 34. |
- Gustafsson, L., et al.
(författare)
-
Low efficiency of cytologic screening for cancer in situ of the cervix in older women
- 1995
-
Ingår i: International Journal of Cancer. - 0020-7136 .- 1097-0215. ; 63:6, s. 804-809
-
Tidskriftsartikel (refereegranskat)abstract
- Cytologic screening for cervical cancer has proven to be beneficial in many countries, although the value of this intervention in women older than 50 years remains controversial. The purpose of this study was to investigate the efficiency of detecting cancer in situ by means of a cytologic smear at different ages, with special emphasis on the benefit of screening in women above the age of 50. We analyzed 466,275 smears taken in an open cohort of 118,890 women in Sweden between 1969 and 1988. The number of cancers in situ detected per 1,000 smears, the detection ratio, was used as an outcome measure in univariate analyses and in multivariate regression models. Cancer in situ was detected in 1,076 women in the study cohort. The detection ratio peaked at ages 30 to 34 and decreased heavily during the next 15 years of age. The efficiency of taking smears at ages above 50 was only 20 per cent (OR, 0.19; 95% CI, 0.14-0.26) of that at ages 30 to 34. These results were not changed when adjusting for time period and time interval since the previous smear. In spite of a high incidence of invasive cervical cancer in older women, the benefit of cytologic screening to detect cancer in situ above the age of 50 is uncertain.
|
|
| 35. |
- Haese, A, et al.
(författare)
-
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade
- 2005
-
Ingår i: Journal of Urology. - : Ovid Technologies (Wolters Kluwer Health). - 1527-3792 .- 0022-5347. ; 173:3, s. 752-756
-
Tidskriftsartikel (refereegranskat)abstract
- Purpose: Previously human glandular kallikrein 2 (hK2) has been implicated to predict pathologically organ confined prostate cancer (PCa) in patients with stage T2 disease. Now we evaluated the usefulness of hK2, as measured by 2 entirely different immunoassay designs, to enhance the discrimination of pathologically organ from nonorgan confined clinical stage T1c PCa. Materials and Methods: A consecutive series of pretreatment serum from 148 men with clinical stage T1c PCa was used in 2 equally sensitive and specific methods to measure total hK2 with independent reagents and entirely different assay designs. Total prostate specific antigen (tPSA) and free PSA (fPSA) were measured and percent fPSA was calculated. We determined the algorithm, hK2*tPSA/fPSA, from data generated by each hK2 assay, calculated means, medians and ranges for each analyte and algorithm, and calculated the significance of differences on univariate analysis. Using pretreatment PSA, clinical stage and biopsy Gleason grade we then developed a multivariate logistic regression base model to predict organ confined cancer and we compared predictions of the base model supplemented by the different hK2 measurements. Results: hK2 and hK2 based algorithms obtained by each hK2 assay were significantly different for pT2a/b vs pT3a or greater PCa (p = 0.034 to 0.0001) compared to tPSA (p = 0.06), fPSA (p = 0.90) or percent fPSA (p = 0.059). However, AUC (0.67 to 0.70) calculated by ROC analysis of the 4 models containing hK2 derived information was not significantly larger than that of the base model (AUC = 0.64, p = 0.52). Conclusions: The current data confirm that hK2 alone or hK2*tPSA/fPSA measured by 2 immunoassays is significantly lower in men with pT2a/b vs pT3a or greater PCa compared to tPSA, fPSA or percent fPSA on univariate analysis of a validation set of clinical stage T1c prostate cancer treated at an American center of excellence for prostate cancer surgery. However, the incorporation of preoperative hK2 into multiparameter predictive models for pT2 cancers did not increase predictive accuracy in this cohort of men.
|
|
| 36. |
- Haese, Alexander, et al.
(författare)
-
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml
- 2001
-
Ingår i: The Prostate. - : Wiley. - 0270-4137 .- 1097-0045. ; 49:2, s. 101-109
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: We measured serum levels of human glandular kallikrein 2 (hK2) in patients treated with radical retropubic prostatectomy (rrP) for clinically localized prostate cancer (PCa) with a total PSA (tPSA)-level below 10 ng/ml to investigate whether hK2 can be applied to preoperatively distinguish organ-confined (pT2a/b) from nonorgan-confined (> or = pT3a)-PCa more accurately than total PSA. Further, we evaluated hK2, free- and tPSA-concentrations in all pathologic stages of PCa. METHODS: 161 serum samples from men scheduled for rrP were collected 1 day before surgery prior to any prostatic manipulation. Pathologic work-up revealed > or = pT3a-PCa in 48 and pT2a/b-PCa in 113 patients. HK2-levels in serum were measured using an immunofluorometric assay with an analytical sensitivity of 0.5 pg/ml, a functional sensitivity of 5 pg/ml and insignificant cross-reactivity with PSA (< 0.005%). Total (tPSA) and free PSA (fPSA) levels were measured using a commercially available assay from which we calculated %fPSA and an algorithm that combined hK2 and PSA-levels [hK2] x [tPSA/fPSA]. Means, medians, and ranges were calculated for pT2a/b vs. >/= pT3a-PCa and for all pathologic stages. Statistical significance of differences was calculated using Mann-Whitney-U and Kruskal-Wallis tests. Calculation of receiver-operator-characteristic (ROC) curves were performed for hK2, [hK2] x [tPSA/fPSA] and tPSA to compare diagnostic performance. RESULTS: A mean tPSA level in serum of 6.12 ng/ml in > or = pT3a-PCa was not significantly different (P = 0.366) from 5.78 ng/ml in pT2a/b-PCa. Also, there were no statistically significantly different levels of fPSA (P = 0.947) or %fPSA (0.292) for these two groups. By contrast, mean hK2-level in pT2a/b-PCa of 80 pg/ml was significantly different (P = 0.004) from a mean hK2 level of 120 pg/ml in > or = pT3a-PCa as shown by Mann-Whitney-analysis Moreover, the algorithm of [hK2] x [tPSA/fPSA] was significantly lower (P = 0.0004) in pT2a/b-PCa vs. > or = pT3a-PCa. Calculation of areas under curve (AUC) by receiver-operator-characteristics (ROC) demonstrated that the AUC for hK2 (0.64) was larger and the AUC for [hK2] x [tPSA/fPSA] (=0.68) significantly larger (P = 0.007) compared to the AUC of tPSA (0.55). Furthermore, Kruskal-Wallis Test revealed a highly significant correlation to pathologic stage using hK2 (P = 0.008) and [hK2] x [tPSA/fPSA] (P = 0.0015) compared to no significant differences in serum concentration of tPSA (P = 0.296). Also at tPSA-levels from 10-20 ng/ml, the hK2-levels in pT2a/b-PCa were close to significantly different (P = 0.051) from those in men with >/= pT3a-PCa, while the algorithm of [hK2] x [tPSA/fPSA] in that tPSA-range was significantly lower (P = 0.002) in pT2a/b-PCa compared to > or = pT3a0-PCa. CONCLUSIONS: Highly significant differences in serum concentration enable hK2 to be a powerful predictor of organ-confined disease and pathologic stage of clinically localized prostate cancer, especially in the PSA-range below 10 ng/ml. As such, there are important clinical consequences for the application of hK2 for the adequate treatment of prostate cancer patients, i.e., the option of nerve-sparing surgery.
|
|
| 37. |
- Hayden (Pettersson), Hans, 1965-
(författare)
-
Gregor Paulsson och den konsthistoriska tolkningens problem
- 1997
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- The core of this thesis is a critical reading of the Swedish art historian Gregor Paulsson's (1889-1977) method of historical interpretation. Initially; Paulsson developed his scholary perspectivefrom the tradition of formalist aesthetics dominating Swedish art history writing in thebeginning of the 20th century. His approach to art history radicaIly changed by the end of the1910's, when he came in touch with experimental psychology. From his own experiments inartistic creativity, he concluded that the governing factor in this process was the ability toapprehend meaning. Paulsson defined the work of art as a homogeneous and ambiguous symbol,which, within its form, combines many different levels of meaning. The task of art historicalinterpretation was to map the meanings carried by the symbol.In his mature works, from the 1930's onward, Paulsson developed these thoughts into a methodof interpretation, dealing both with the psychological and social dimensions of the work of art.Through the concepts of "field" and "function", he tried to reconstruct the original value andmeaning of the work of art and buildings. Thus, he was able to expand the field of research for arthistorians to include all manner of forms and objects of the human environment. In his method,Gregor Paulsson tried to unite the old scholary ideal of a comprehensive system, where all aspectscould be interpreted with reference to each other and to the whole, with the results and theories ofmodern, specialized sciences. His vision was to create a theoretical foundation for a new field ofresearch, which he described as an "aesthetic enviromental morphology".
|
|
| 38. |
- Hedman, Christina, 1964-, et al.
(författare)
-
Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF-I and IGFBP-1 in type 1 diabetes
- 2001
-
Ingår i: Clinical Endocrinology. - : Wiley. - 0300-0664 .- 1365-2265. ; 55:1, s. 107-112
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE IGF-I levels in patients with type 1 diabetes without endogenous insulin production are low. Our aim was to examine whether the plasma insulin profile obtained by treatment with the insulin analogue lispro has a different effect on plasma concentrations of IGF-I and IGFBP-1 than that seen during treatment with conventional human insulin (regular insulin).DESIGN AND PATIENTS Twelve patients with type 1 diabetes, age 47·8 ± 2·4 years (mean ± SEM), body mass index 26·5 ± 1·0 kg/m2, diabetes duration 30·5 ± 3·2 years participated in this open label randomized cross-over study. IGF-I and IGFBP-1 levels were measured at the end of 6 weeks treatment with each insulin being administered by a continuous subcutaneous insulin infusion. IGF-I was measured fasting while IGFBP-1, free insulin and blood glucose were measured fasting and repeatedly after a morning meal preceded by an insulin bolus dose.RESULTS Lispro gave a marked insulin peak of 135 ± 20 pmol/l 50 minutes after injection. After an initial rapid rise, human regular insulin reached a plateau of approximately 50 pmol/l. The plasma free insulin area under the curve (AUC) from 0710 h to 0910 h was more than twice as large on lispro as on regular insulin (P = 0·01). Plasma IGF-I concentration was 78·8 ± 10·9 µg/l on lispro and 82·3 ± 10·5 µg/l on human regular insulin (not significant). AUC for IGFBP-1 did not show a significant difference even when divided from 0710 h to 0910 h and from 0930 h to 1430 h. Blood glucose AUC after administration of the bolus was significantly lower during treatment with lispro (P = 0·006) but glycosylated haemoglobin (HbA1c) was 6·4 ± 0·2% on both therapies.CONCLUSIONS Our results indicate that the effect of lispro on IGF-I and IGFBP-1 in patients with type 1 diabetes does not differ from that of human regular insulin.
|
|
| 39. |
|
|
| 40. |
|
|
| 41. |
- Hollenberg, Jacob, et al.
(författare)
-
Dual dispatch early defibrillation in out-of-hospital cardiac arrest: the SALSA-pilot
- 2009
-
Ingår i: European Heart Journal. - : Oxford University Press. - 0195-668X .- 1522-9645. ; 30:14, s. 1781-9
-
Tidskriftsartikel (refereegranskat)abstract
- AIMS: Out-of-hospital cardiac arrest (OHCA) is a major public health problem. The objective of this study is to explore the effects of a dual dispatch early defibrillation programme. METHODS AND RESULTS: In this pilot study, automated external defibrillators (AEDs) were provided to all 43 fire stations in Stockholm during 2005. Fire-fighters were dispatched in parallel with traditional emergency medical responders (EMS) to all suspected cases of OHCA. Additionally, 65 larger public venues were equipped with AEDs. All 863 OHCA from December 2005 to December 2006 were included during the intervention, whereas all 657 OHCA from 2004 served as historical controls. Among dual dispatches, fire-fighters assisted with cardiopulmonary resuscitation (CPR) in 94% of the cases and arrived first on scene in 36%. The median time from call to arrival of first responder decreased from 7.5 min during the control period to 7.1 min during the intervention (P = 0.004). The proportion of patients in shockable rhythm remained unchanged. The proportion of patients alive 1 month after OHCA rose from 4.4 to 6.8% [adjusted odds ratio (OR): 1.6; 95% confidence interval (CI): 0.9-2.9]. One-month survival in witnessed cases rose from 5.7 to 9.7% (adjusted OR: 2.0; 95% CI: 1.1-3.7). Survival after OHCA in the rest of Sweden (Stockholm excluded) declined from 8.3 to 6.6% during the corresponding time period (unadjusted OR: 0.8; 95% CI: 0.6-1.0). Only three OHCA occurred at public venues equipped with AEDs. CONCLUSION: An introduction of a dual dispatch early defibrillation programme in Stockholm has shortened response times and is likely to have improved survival in patients with OHCA, especially in the group of witnessed cardiac arrests. The increase in survival is believed to be associated with improved CPR and shortened time intervals.
|
|
| 42. |
|
|
| 43. |
- Holmström, Anna, et al.
(författare)
-
LcrV is a channel size-determining component of the Yop effector translocon of Yersinia
- 2001
-
Ingår i: Molecular Microbiology. - : Blackwell Publishing. - 0950-382X .- 1365-2958. ; 39:3, s. 620-632
-
Tidskriftsartikel (refereegranskat)abstract
- Delivery of Yop effector proteins by pathogenic Yersinia across the eukaryotic cell membrane requires LcrV, YopB and YopD. These proteins were also required for channel formation in infected erythrocytes and, using different osmolytes, the contact‐dependent haemolysis assay was used to study channel size. Channels associated with LcrV were around 3 nm, whereas the homologous PcrV protein of Pseudomonas aeruginosa induced channels of around 2 nm in diameter. In lipid bilayer membranes, purified LcrV and PcrV induced a stepwise conductance increase of 3 nS and 1 nS, respectively, in 1 M KCl. The regions important for channel size were localized to amino acids 127–195 of LcrV and to amino acids 106–173 of PcrV. The size of the channel correlated with the ability to translocate Yop effectors into host cells. We suggest that LcrV is a size‐determining structural component of the Yop translocon.
|
|
| 44. |
- Holmström, Anna, et al.
(författare)
-
YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane
- 1997
-
Ingår i: Molecular Microbiology. - : Wiley. - 0950-382X .- 1365-2958. ; 24:1, s. 73-91
-
Tidskriftsartikel (refereegranskat)abstract
- Introduction of anti-host factors into eukaryotic cells by extracellular bacteria is a strategy evolved by several Gram-negative pathogens. In these pathogens, the transport of virulence proteins across the bacterial membranes is governed by closely related type III secretion systems. For pathogenic Yersinia, the protein transport across the eukaryotic cell membrane occurs by a polarized mechanism requiring two secreted proteins, YopB and YopD. YopB was recently shown to induce the formation of a pore in the eukaryotic cell membrane, and through this pore, translocation of Yop effectors is believed to occur (Håkansson et al., 1996b). We have previously shown that YopK of Yersinia pseudotuberculosis is required for the development of a systemic infection in mice. Here, we have analysed the role of YopK in the virulence process in more detail. A yopK-mutant strain was found to induce a more rapid YopE-mediated cytotoxic response in HeLa cells as well as in MDCK-1 cells compared to the wild-type strain. We found that this was the result of a cell-contact-dependent increase in translocation of YopE into HeLa cells. In contrast, overexpression of YopK resulted in impaired translocation. In addition, we found that YopK also influenced the YopB-dependent lytic effect on sheep erythrocytes as well as on HeLa cells. A yopK-mutant strain showed a higher lytic activity and the induced pore was larger compared to the corresponding wild-type strain, whereas a strain overexpressing YopK reduced the lytic activity and the apparent pore size was smaller. The secreted YopK protein was found not to be translocated but, similar to YopB, localized to cell-associated bacteria during infection of HeLa cells. Based on these results, we propose a model where YopK controls the translocation of Yop effectors into eukaryotic cells.
|
|
| 45. |
- Ingelsson, Martin, et al.
(författare)
-
Sällsynta mutationer leder till framtidens behandling
- 2009
-
Ingår i: Läkartidningen. - 0023-7205 .- 1652-7518. ; 106:20, s. 1396-1400
-
Tidskriftsartikel (refereegranskat)abstract
- The identification of disease-causing mutations in Alzheimer’s disease has greatly contributed to our understanding of the pathogenesis. Based on this knowledge, a number of therapeutic strategies are under development, most of which are aimed at lowering the amount of Abpeptides in the affected brain. Due to intense research efforts and massive investments at universities and in the pharmaceutical industry, the future perspectives for Alzheimer patients have never looked brighter.
|
|
| 46. |
- Jamil, Momin, et al.
(författare)
-
Cross-ambiguity function of weighted pulse trains with Oppermann sequences
- 2009
-
Konferensbidrag (refereegranskat)abstract
- The design of integrated radar and communication systems may be based on sets of polyphase sequences such as Oppermann sequences. In this paper, we derive an analytical expression for the cross-ambiguity function of weighted pulse trains with Oppermann sequences. Further, the auto-ambiguity function is deduced from this as a special case. Numerical examples are provided to illustrate the relationship between sequence parameters and performance characteristics.
|
|
| 47. |
- Jamil, Momin, et al.
(författare)
-
On Integrated Radar and Communication Systems Using Oppermann Sequences
- 2008
-
Konferensbidrag (refereegranskat)abstract
- In this paper, we consider the design of integrated radar and communication systems that utilize weighted pulse trains with the elements of Oppermann sequences serving as complex-valued weights. An analytical expression of the ambiguity function for weighted pulse trains with Oppermann sequences is derived. Given a family of Oppermann sequences, it is shown that the related ambiguity function depends only on one sequence parameter. This property simplifies the design of the associated weighted pulse trains as it constrains the degrees of freedom. In contrast to the single polyphase pulse compression sequences that are typically deployed in radar applications, the families considered in this paper form sets of sequences. As such, they readily facilitate also multiple-access in communication systems. Numerical examples are provided that show the wide range of options offered by Oppermann sequences in the design of integrated radar and communication systems.
|
|
| 48. |
- Jamil, Momin, et al.
(författare)
-
Performance Assessment of Polyphase Pulse Compression Codes
- 2008
-
Konferensbidrag (refereegranskat)abstract
- The performance of conventional polyphase pulse compression codes such as the Frank, Frank-Zadoff-Chu (FZC), P1, P2, P3, P4, and Px codes will be compared with Oppermann codes. While the majority of the former code classes focus on radar applications, Oppermann codes have been discussed only within the context of code-division multiple-access (CDMA) systems. In this paper, we therefore consolidate findings on the conventional codes and extend the performance assessment to Oppermann codes by accounting for Doppler shifts as needed in radar applications. It is shown that Oppermann codes can conceptually support integrated radar and communication systems as compared to the P1, P2, P3, P4, and Px codes where this is not readily feasible. The numerical results given here illustrate that Oppermann codes outperform Px codes in the presence of Doppler shifts as supported by the ambiguity function.
|
|
| 49. |
- Jamil, Momin, et al.
(författare)
-
Properties of ambiguity functions for weighted pulse trains with oppermann sequences
- 2009
-
Konferensbidrag (refereegranskat)abstract
- In this paper, we consider properties of the autoambiguity and cross-ambiguity functions of weighted pulse trains with Oppermann sequences. Several properties are examined and proved which in turn allows for reducing the design space for optimization of a particular design. The insights gained from these properties are consolidated in a formal framework leading to procedures that can be used for a more structured waveform design. Numerical examples are provided to illustrate the relationship between sequence parameters and performance characteristics.
|
|
| 50. |
|
|
